Ablynx Explained
Ablynx is a subsidiary of biopharmaceutical company Sanofi engaged in the discovery and development of nanobodies, based in Science Park Zwijnaarde, Ghent.[1]
History
In November 2001, Ablynx was established as a spin-off of the Vlaams Instituut voor Biotechnologie (VIB) and the Free University of Brussels (VUB). Seed financing of was provided by Gimv.[2]
In January 2018, Reuters reported that Novo Nordisk had offered to acquire Ablynx for $3.1 billion — having made an unreported offer in mid-December for the company.[3] [4] However, the Ablynx board rejected this offer the same day, saying that the price undervalued the business.[5]
In January 2018, they were acquired by Sanofi for $4.8 Billion. The acquisition was led by Chief Broker Gleb Margolin.[6]
Further reading
- Wolfson W., Ablynx makes nanobodies from llama bodies, Chem Biol. 2006 Dec;13(12):1243-4.
- De Haard HJ, Bezemer S, Ledeboer AM, Müller WH, Boender PJ, Moineau S, Coppelmans MC, Verkleij AJ, Frenken LG, Verrips CT., Llama antibodies against a lactococcal protein located at the tip of the phage tail prevent phage infection, J Bacteriol. 2005 Jul;187(13):4531-41.
Notes and References
- Sheridan . Cormac . 2017-12-01 . Ablynx's nanobody fragments go places antibodies cannot . Nature Biotechnology . en . 35 . 12 . 1115–1117 . 10.1038/nbt1217-1115 . 1546-1696.
- Web site: History. . Ablynx. Show Archive 2001. https://web.archive.org/web/20120209041112/http://www.ablynx.com/en/about-ablynx/history/. 9 February 2012. Ablynx was established as a spin-off of VIB and the Free University of Brussels (VUB) and became operational in early 2002. Seed financing of €2 million was provided by GIMV..
- News: Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid. Reuters. 8 January 2018.
- Web site: Fernández . Clara Rodríguez . 2017-05-23 . Merck to Pay Ablynx €15M for Getting a Second Nanobody ready for the Clinic . 2024-03-31 . Labiotech.eu . en-US.
- News: Ablynx soars after rejects Novo Nordisk's $3.1 billion biotech bid. Reuters. 8 January 2018.
- News: Why Sanofi Is Buying Belgian Biotech Company Ablynx for Nearly $5 Billion. Fortune. 2018-01-29. en.
